4-aminopiperidine derivatives

Details for Australian Patent Application No. 2005318597 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Ricklin, Fabienne; Boehringer, Markus; Kuhn, Bernd; Luebbers, Thomas; Hunziker, Daniel; Loeffler, Bernd Michael

Agent Spruson & Ferguson

Pub. Number AU-A-2005318597

PCT Pub. Number WO2006/066747

Priority 04106711.7 20.12.04 EP

Filing date 12 December 2005

Wipo publication date 29 June 2006

International Classifications

C07D 211/58 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

A61K 31/4468 (2006.01) - having a nitrogen atom directly attached in position 4, e.g. clebopride, fentanyl

A61K 31/45 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. cycloheximide

C07D 211/60 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 277/04 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

Event Publications

12 July 2007 PCT application entered the National Phase

  PCT publication WO2006/066747 Priority application(s): WO2006/066747

5 July 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005318598-Tetralin and indane derivatives and uses thereof as 5-HT antagonists

2005318596-Chroman derivatives and their use as 5-HT receptor ligands